Lung Disease: Clinical Trials & Testing


  • 肺功能测试、集中式肺活量计和呼出气一氧化氮(FeNO)
  • 高分辨率计算机断层扫描(HRCT)
  • 运动能力测试,包括6分钟步行测试(6MWT)和运动心肺功能测试(CPET)
  • 用于生物标记物测定、微生物学和细胞学的痰取样和处理
  • 支气管肺泡灌洗检查(BAL)
  • 患者报告的结果(ePRO /日记)和问卷调查
Clinical trials for respiratory and lung disease


We've . . . 
  • Supported over 550 immune-mediated inflammatory disease (IMID) clinical trials in the past five years, including more than 90 asthma, 65 COPD, 20 CF and 20 IPF trials.
  • Managed at least 1 IPF trial per year since 2004.
  • Participated in more than 165 studies involving pediatric patients, equating to approximately 20% of all U.S. pediatric trials.

Laboratory Testing

  • Over 90 protocols for asthma and 65 for COPD. 
  • Patients represent the following countries: United States, United Kingdom, Poland, Germany, China, New Zealand, Japan, Russia, Belgium and Ukraine. 
  • To date, we've completed testing in over 50 countries at more than 6,000 sites, representing more than 80,000 patients. 
  • Download our infographic 

• 超过175,000名临床试验研究者 • 超过793,000名医生 • 超过150亿项实验室测试结果 • 超过16,000项临床试验方案


  • Access more than 150,000 asthma/COPD patients via partnership sites. 
  • Target experienced sites with high recruitment rates using Xcellerate® Trial Design
  • Utilize specialist inflammatory biomarker analysis, e.g. eosinophil cationic protein and periostin
  • Access more than 3,000 asthma and more than 2,500 COPD investigators worldwide
  • Select the highest-ranking investigators using our investigator performance database 
  • Partner with a single organization that offers device testing, in vitro diagnostics, clinical trials and inhalation routes of administration. 
  • Work with a global, dedicated inhalation team and facilities. 
  • 集中而客观的终点分析,以减少差异性
  • 确保有适当的仪器可用,并提供针对研究的仪器使用以及数据采集、处理和解释方面的培训
  • Understand how devices patents (i.e. for inhalation devices) are different than pharma patents 
  • Use effective reimbursement strategies and patient follow-up for patients struggling with respiratory and lung disease
  • 儿科试验方案设计与实施方面的专业知识
  • 识别和支持表现优异的儿科研究者
  • 制定儿科研发计划,并在药物研发进程早期与监管机构往来交流
  • 运用患者意见和/或家长的深度观察结论了解患者挑战,并纳入试验设计
  • 满足患者和家庭需要的试验中心基础设施